NCT02394886View on ClinicalTrials.gov

Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

July 31, 2015

Conditions
Diabetic Foot Ulcer
Interventions
BIOLOGICAL

ALLO-ASC-DFU

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

All Listed Sponsors
lead

Anterogen Co., Ltd.

INDUSTRY

NCT02394886 - Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter